DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+11.8%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.54B
AUM Growth
+$2.54B
(+8.3%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
129
New
21
Increased
16
Reduced
23
Closed
20
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$38M |
| 2 |
ADPT
Adeptus Health Inc.
ADPT
|
$33.3M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$30.2M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$29.1M |
| 5 |
Glaukos
GKOS
|
$28.7M |
Top Sells
| 1 |
GSK
GSK
|
$67.9M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$35.7M |
| 3 |
AET
Aetna Inc
AET
|
$27.5M |
| 4 |
McKesson
MCK
|
$27.5M |
| 5 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$27.4M |
Sector Composition
| 1 | Healthcare | 68.67% |
| 2 | Financials | 3.21% |
| 3 | Industrials | 0.75% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $226M | 8.89% | 13,740,261 | – | – |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $97.7M | 3.84% | 4,505,468 -1,000,560 | -18% | -$21.7M |
|
|
GWPH
3
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $90.8M | 3.57% | 991,800 +317,427 | +47% | +$29.1M |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $86.7M | 3.41% | 3,673,727 +583,942 | +19% | +$13.8M |
|
|
AVXS
5
DELISTED
AveXis, Inc. Common Stock
AVXS
| $85M | 3.34% | 2,236,701 | – | – |
|
|
ADPT
6
DELISTED
Adeptus Health Inc.
ADPT
| $82.7M | 3.25% | 1,600,861 +644,328 | +67% | +$33.3M |
|
|
XNPT
7
DELISTED
XENOPORT, INC.
XNPT
| $81.5M | 3.2% | 11,572,125 | – | – |
|
8
Vanda Pharmaceuticals
VNDA
$279M
| $67.1M | 2.64% | 5,996,691 | – | – |
|
9
Viatris
VTRS
$12.3B
| $57.9M | 2.28% | 1,339,334 -493,201 | -27% | -$21.3M |
|
|
DBVT
10
DBV Technologies
DBVT
$264M
| $56.9M | 2.23% | 1,743,229 +925,423 | +113% | +$30.2M |
|
11
Xencor
XNCR
$580M
| $55.7M | 2.19% | 2,930,486 -537,026 | -15% | -$10.2M |
|
|
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
| $50.9M | 2% | 611,457 +100,000 | +20% | +$8.33M |
|
|
AAC
13
DELISTED
AAC Holdings, Inc.
AAC
| $49.1M | 1.93% | 2,149,702 -145,234 | -6% | -$3.31M |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $44.7M | 1.76% | 366,000 -225,465 | -38% | -$27.5M |
|
|
AERI
15
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $44.4M | 1.74% | 2,520,585 -111,897 | -4% | -$1.97M |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $43.7M | 1.72% | 4,072,809 | – | – |
|
17
Editas Medicine
EDIT
$231M
| $41.7M | 1.64% | 1,709,400 | – | – |
|
18
DaVita
DVA
$9.85B
| $40.6M | 1.6% | 525,000 -297,000 | -36% | -$23M |
|
|
SYRS
19
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $38M | 1.49% | +2,095,220 | New | +$38M |
|
20
eHealth
EHTH
$118M
| $37M | 1.46% | 2,640,609 -623,979 | -19% | -$8.75M |
|
|
ZLTQ
21
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $35.4M | 1.39% | 1,297,000 +192,583 | +17% | +$5.26M |
|
|
UAM
22
DELISTED
Universal American Corp
UAM
| $32.8M | 1.29% | 4,323,000 -962,500 | -18% | -$7.3M |
|
|
RLYP
23
DELISTED
RELYPSA INC COM
RLYP
| $30.9M | 1.21% | 1,670,383 -203,088 | -11% | -$3.76M |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $29.8M | 1.17% | 8,361,069 -1,168,292 | -12% | -$4.16M |
|
|
TVTY
25
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $29.4M | 1.15% | 2,541,686 +66,299 | +3% | +$766K |
|